Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Hyatt Regency Bethesda

19 oct 2015 7:00 a.m. - 20 oct 2015 4:30 p.m.

One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814-5326

Biosimilars 2015

Interact with FDA and international agencies to discuss the latest updates and outlooks for biosimilar regulation, while examining the potential implications for patients and HCPs.

Session Chair(s)

Sundar  Ramanan, PHD

Sundar Ramanan, PHD

Director, Global Biosimilars R&D Policy

Amgen Inc., United States

Speaker(s)

Joseph L Glajch

Panelists

Joseph L Glajch

Momenta Pharmaceuticals, United States

Director, Analytical Development

Steven  Kozlowski, MD

Steven Kozlowski, MD

FDA, United States

Director, Office of Biotechnology Products, OPQ, CDER

Paul  Tebbey, PHD, MBA

Paul Tebbey, PHD, MBA

AbbVie, Inc., United States

Therapeutic Area Lead, Biotherapeutics Global Medical Affairs

Brad  Jordan, PHD

Brad Jordan, PHD

Eli Lilly and Company, United States

Associate Vice President, Regulatory Policy and Strategy

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.